Screener
Candel Therapeutics, Inc. CADL Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
FAQ
- What is Candel Therapeutics, Inc.'s price / book?
- Candel Therapeutics, Inc. (CADL) reported price / book of 2.6× in Q1 2026.
- How has Candel Therapeutics, Inc.'s price / book changed year-over-year?
- Candel Therapeutics, Inc.'s price / book decreased by 27.2% year-over-year, from 3.6× to 2.6×.
- What is the long-term trend for Candel Therapeutics, Inc.'s price / book?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s price / book has grown at a 14.3% compound annual growth rate (CAGR), from 3.5× to 6×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Candel Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude